Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9815	Companies
196895	Keywords
127961	Articles
104711	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 01/06/2026 at 15:05, 30 days 9 hours ago

Le crofelemer de Jaguar Health se révèle prometteur dans le traitement de l'insuffisance intestinale.

Crofelemer Jaguar Health Étude Pédiatrique Insuffisance Intestinale Soutien Parentéral
PRESS RELEASE

published on 01/06/2026 at 15:00, 30 days 10 hours ago

Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication
Jaguar Health announced groundbreaking results from ongoing proof-of-concept study of crofelemer in pediatric patients with intestinal failure, showing significant reduction of parenteral support (PS) and potential to save lives

Crofelemer Jaguar Health Pediatric Patients Intestinal Failure Parenteral Support
BRIEF

published on 01/02/2026 at 15:05, 1 month 3 days ago

Jaguar Health Secures FDA Grant for Canalevia-CA1 Studies

Veterinary Medicine Jaguar Health Canalevia-CA1 Dog Diarrhea Treatment FDA Grant
BRIEF

published on 01/02/2026 at 15:05, 1 month 3 days ago

Jaguar Health obtient une subvention de la FDA pour des études sur Canalevia-CA1

Jaguar Health Canalevia-CA1 Médecine Vétérinaire Subvention De La FDA Traitement De La Diarrhée Chez Le Chien
PRESS RELEASE

published on 01/02/2026 at 15:00, 1 month 3 days ago

Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. receives $240,000 grant from FDA for Canalevia-CA1 study on chemotherapy-induced diarrhea in dogs. Focus on CID treatment effectiveness

Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Grant Dogs
BRIEF

published on 12/15/2025 at 15:05, 1 month 21 days ago

Jaguar Health soumet un résumé pour un essai clinique sur le crofélémer chez des patients atteints du syndrome de l'intestin court avec insuffisance intestinale.

Jaguar Health Syndrome De L'intestin Court Médicament Orphelin Insuffisance Intestinale Procès Crofelemer
BRIEF

published on 12/15/2025 at 15:05, 1 month 21 days ago

Jaguar Health Submits Abstract for Crofelemer Trial in SBS-IF Patients

Short Bowel Syndrome Jaguar Health Orphan Drug Crofelemer Trial Intestinal Failure
PRESS RELEASE

published on 12/15/2025 at 15:00, 1 month 21 days ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Jaguar Health announces submission of abstract detailing preliminary findings from clinical trial on a novel oral liquid formulation of crofelemer for SBS-IF patients, supporting the focus on reducing PS needs in intestinal failure patients

Crofelemer Jaguar Health Clinical Trial SBS-IF Intestinal Failure
BRIEF

published on 12/10/2025 at 15:05, 1 month 26 days ago

La FDA prolonge l'approbation conditionnelle du Canalevia-CA1 de Jaguar Health

Jaguar Health Canalevia-CA1 Approbation De La FDA Médecine Vétérinaire Chimiothérapie Chez Les Chiens
BRIEF

published on 12/10/2025 at 15:05, 1 month 26 days ago

FDA Extends Conditional Approval for Jaguar Health's Canalevia-CA1

FDA Approval Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy In Dogs

Accesswire

Published on 02/06/2026 at 00:57, 4 minutes ago

Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 1 hour 1 minute ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 1 hour 46 minutes ago

Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 23:00, 2 hours 1 minute ago

Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/05/2026 at 21:00, 4 hours 1 minute ago

Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 19:27, 5 hours 33 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 6 hours 14 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 6 hours 51 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 7 hours 5 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 7 hours 21 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.

Les Echos

Published on 02/05/2026 at 19:24, 5 hours 36 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 5 hours 36 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 5 hours 46 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 5 hours 46 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 5 hours 46 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE